Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Novo Nordisk (NVO)

2014-11-28@07:49:01 ET
Global Diabetes Market Report: 2014 Edition (MTO)

2014-11-27@10:58:13 ET
Global Insulin Industry Report 2014 (MTO)

2014-11-26@11:56:50 ET
Sunshine Healthcare declares No-Sugar Day (ABW)

2014-11-26@10:00:08 ET
Novo Nordisk Case Study Shows Path to Lowering Costs and Improving Diabetes Care in Turkey (TBL)

2014-11-25@07:10:34 ET
Novo Nordisk's Victoza Recommended for Label Expansion (ZAX)

2014-11-24@16:31:03 ET
Novo Nordisk A/S: Changes in Novo Nordisk's Executive Management (PMZ)

2014-11-24@11:02:14 ET
Novo Nordisk Grant Enables Trenton Health Team to Engage Faith-Based Organizations in Program for Healthy Living (PRW)

2014-11-24@07:42:14 ET
Novo Nordisk A/S - Share repurchase programme (PMZ)

2014-11-24@04:25:18 ET

2014-11-20@20:07:12 ET
Novo Nordisk grabs 2nd best position (ABW)

2014-11-20@08:19:51 ET
Relatively Good Performance Detected in Shares of Impax Laboratories in the Pharmaceuticals Industry (IPXL, AZN, NVO, AUXL, RHHBY) (F70)

2014-11-19@17:51:44 ET
Look for Shares of Novo Nordisk to Potentially Pullback after Yesterday's 1.18% Rise (PSM)

2014-11-18@08:39:35 ET
GlaxoSmithKline leads Access to Medicine Index (ABW)

2014-11-18@08:27:50 ET
Bottom 5 Companies in the Pharmaceuticals Industry with the Lowest Relative Performance (JAZZ, NVO, SLXP, POZN, AKRX) (F70)

2014-11-18@01:12:51 ET
US Patent Issued to Novo Nordisk on Nov. 11 for "Single-chain insulin" (Danish Inventors) (ABW)

2014-11-17@12:18:38 ET
Novo Nordisk Crosses Below its 10-day MA (NVO) (F78)

2014-11-17@11:43:23 ET
'Run for Changing Diabetes' (ABW)

2014-11-17@10:00:09 ET
Novo Nordisk Second Best in the World at Providing Access to Medicine (TBL)

2014-11-17@09:25:30 ET
Global Pen Needles Market Report 2014-2019: Type (Standard and Safety), Needle Length (4, 5, 6, 8, 10, 12mm) &Therapy (Insulin, Glucagon-like peptide, Growth Hormones) Analysis (MTO)

2014-11-17@08:19:36 ET
Novo Nordisk A/S - Share repurchase programme (PMZ)